TuHURA Biosciences (HURA) Interest Expenses (2011 - 2026)
TuHURA Biosciences' (HURA) quarterly Interest Expenses came in at $9.5 million in Q1 2026, up 703.04% year-on-year from $1.2 million in Q1 2025, and up 1818.1% quarter-over-quarter from $495283.0 in Q4 2025.
TuHURA Biosciences (HURA) Interest Expenses (2011 - 2026) Analysis & Trends
TuHURA Biosciences' Interest Expenses history runs 16 years deep, the most recent figure standing at $9.5 million for Q1 2026.
- On a quarterly basis, Interest Expenses rose 703.04% year-over-year to $9.5 million in Q1 2026; TTM through Mar 2026 was $9.5 million, a 703.04% increase from a year earlier, with the FY2025 full-year figure at $625283.0, down 98.66% from the prior year.
- Interest Expenses improved to $9.5 million in Q1 2026 per HURA's latest filing, from $495283.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $32.4 million in Q2 2023 and bottomed at $255122.0 in Q1 2024.
- The 5-year median for Interest Expenses is $2.6 million (2024), against an average of $8.9 million.
- Across the five-year window, Interest Expenses surged 399671.43% in 2022 and plunged 95.02% in 2024, its largest moves.
- Year by year, Interest Expenses stood at $28.0 million in 2022, then retreated by 23.88% to $21.3 million in 2023, then tumbled by 74.21% to $5.5 million in 2024, then plunged by 90.99% to $495283.0 in 2025, then jumped by 1818.1% to $9.5 million in 2026.
- Per Business Quant, the three latest HURA Interest Expenses figures stand at $9.5 million (Q1 2026), $495283.0 (Q4 2025), and $1.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 1.17 Bn |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - | 9.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.50 Mn |
| Mar 31, 2026 | 9.50 Mn |
| Dec 31, 2025 | 495,283.00 |
| Dec 31, 2025 | 495,283.00 |
| Sep 30, 2025 | 1.09 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 5.49 Mn |
| Dec 31, 2024 | 5.49 Mn |
| Sep 30, 2024 | 3.62 Mn |
| Sep 30, 2024 | 3.62 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 255,122.00 |
| Mar 31, 2024 | 255,122.00 |
| Dec 31, 2023 | 21.30 Mn |
| Dec 31, 2023 | 21.30 Mn |